Quelles complications peuvent survenir avec le lymphome intraoculaire ?
Les complications incluent la perte de vision, le glaucome et des infections secondaires.
ComplicationsPerte de visionGlaucome
#2
Le lymphome intraoculaire peut-il entraîner des métastases ?
Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare.
MétastasesPropagationRare
#3
Comment le traitement peut-il causer des complications ?
Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections.
ChimiothérapieSystème immunitaireInfections
#4
Le suivi régulier peut-il prévenir les complications ?
Oui, un suivi régulier permet de détecter et de traiter rapidement les complications.
Suivi régulierPréventionComplications
#5
Quelles sont les complications à long terme possibles ?
Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements.
Complications à long termeProblèmes de visionEffets secondaires
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du lymphome intraoculaire ?
Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections.
Facteurs de risqueImmunodépressionInfections
#2
Les antécédents familiaux augmentent-ils le risque ?
Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie.
Antécédents familiauxRisqueLymphome
#3
Les personnes immunodéprimées sont-elles plus à risque ?
Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru.
ImmunodépressionVIHRisque accru
#4
Certaines infections virales sont-elles des facteurs de risque ?
Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome.
Infections viralesVirus Epstein-BarrRisque accru
#5
L'exposition à des produits chimiques augmente-t-elle le risque ?
Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome.
Produits chimiquesExpositionRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphome intraoculaire : Questions médicales les plus fréquentes",
"headline": "Lymphome intraoculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphome intraoculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lymphomes",
"url": "https://questionsmedicales.fr/mesh/D008223",
"about": {
"@type": "MedicalCondition",
"name": "Lymphomes",
"code": {
"@type": "MedicalCode",
"code": "D008223",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire",
"alternateName": "Intraocular Lymphoma",
"code": {
"@type": "MedicalCode",
"code": "D064090",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Gezhi Xu",
"url": "https://questionsmedicales.fr/author/Gezhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Satoru Kase",
"url": "https://questionsmedicales.fr/author/Satoru%20Kase",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Daiju Iwata",
"url": "https://questionsmedicales.fr/author/Daiju%20Iwata",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kayo Suzuki",
"url": "https://questionsmedicales.fr/author/Kayo%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kenichi Namba",
"url": "https://questionsmedicales.fr/author/Kenichi%20Namba",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nutrition for Cancer Survivors.",
"datePublished": "2022-10-01",
"url": "https://questionsmedicales.fr/article/36235745",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14194093"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypertension in Cancer Survivors.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35852781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11906-022-01208-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Survival of cancer survivors with a new pancreatic cancer diagnosis.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35674139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.4903"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep disturbances among cancer survivors.",
"datePublished": "2023-10-12",
"url": "https://questionsmedicales.fr/article/37837808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.canep.2023.102471"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychological and sexual problems of cancer survivors.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37254933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4081/aiua.2023.11473"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndromes immunoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D007160"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndromes lymphoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D008232"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lymphomes",
"item": "https://questionsmedicales.fr/mesh/D008223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphome intraoculaire",
"item": "https://questionsmedicales.fr/mesh/D064090"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphome intraoculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphome intraoculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphome intraoculaire",
"description": "Comment diagnostique-t-on un lymphome intraoculaire ?\nQuels tests sont utilisés pour confirmer le lymphome intraoculaire ?\nQuels signes cliniques indiquent un lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il être confondu avec d'autres maladies ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Cancer+Survivors#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphome intraoculaire",
"description": "Quels sont les symptômes courants du lymphome intraoculaire ?\nLe lymphome intraoculaire cause-t-il des changements de vision ?\nPeut-on avoir des symptômes sans douleur ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Cancer+Survivors#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphome intraoculaire",
"description": "Peut-on prévenir le lymphome intraoculaire ?\nQuels facteurs de risque sont associés au lymphome intraoculaire ?\nLes infections peuvent-elles être évitées pour réduire le risque ?\nLe dépistage précoce aide-t-il à la prévention ?\nY a-t-il des recommandations pour les personnes à risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Cancer+Survivors#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphome intraoculaire",
"description": "Quels traitements sont disponibles pour le lymphome intraoculaire ?\nLa chimiothérapie est-elle efficace pour ce type de lymphome ?\nLa radiothérapie est-elle utilisée dans le traitement ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des traitements expérimentaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Cancer+Survivors#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphome intraoculaire",
"description": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il entraîner des métastases ?\nComment le traitement peut-il causer des complications ?\nLe suivi régulier peut-il prévenir les complications ?\nQuelles sont les complications à long terme possibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Cancer+Survivors#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphome intraoculaire",
"description": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nCertaines infections virales sont-elles des facteurs de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Cancer+Survivors#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un lymphome intraoculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par examen ophtalmologique, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le lymphome intraoculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et l'analyse du liquide vitré."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un lymphome intraoculaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la vision floue, des douleurs oculaires et des lésions rétiniennes peuvent indiquer la maladie."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des infections ou d'autres tumeurs oculaires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'analyser les cellules et de confirmer la présence de lymphome."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du lymphome intraoculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent vision floue, douleur, rougeur et décoloration de l'œil."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire cause-t-il des changements de vision ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des changements de vision, y compris des taches ou des ombres."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des symptômes sans douleur oculaire significative."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'étendue et de la localisation du lymphome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre et la perte de poids peuvent également survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le lymphome intraoculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés au lymphome intraoculaire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, certaines infections virales et l'âge avancé."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être évitées pour réduire le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les infections virales comme le VIH peut réduire le risque de lymphome."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce peut aider à identifier les problèmes oculaires avant qu'ils ne deviennent graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les personnes à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes à risque devraient consulter régulièrement un ophtalmologiste pour un suivi."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le lymphome intraoculaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chimiothérapie, la radiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace pour ce type de lymphome ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent efficace, surtout pour les lymphomes non hodgkiniens."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour cibler les cellules cancéreuses dans l'œil."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si le lymphome provoque des complications ou ne répond pas aux autres traitements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements expérimentaux comme les thérapies ciblées sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, le glaucome et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il entraîner des métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare."
}
},
{
"@type": "Question",
"name": "Comment le traitement peut-il causer des complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Le suivi régulier peut-il prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de détecter et de traiter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru."
}
},
{
"@type": "Question",
"name": "Certaines infections virales sont-elles des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome."
}
}
]
}
]
}
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. Electronic address: qngchang@aliyun.com.
Department of Ophthalmology and Visual Science, Catholic University Lymphoma Group, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
With increasing survival after cancer treatment, there is a need for long-term management of risk factors and chronic medical conditions to realize the full benefit of improvement of outcomes. Hyperte...
A lot of newer anti-cancer therapies have been implicated in the development or worsening of hypertension. We summarize the latest data, explore associations between these therapies and hypertension, ...
Persons newly diagnosed with pancreas cancer and who have survived a previous cancer are often excluded from clinical trials, despite limited evidence about their prognosis. We examined the associatio...
This US population-based cohort study included older adults (aged ≥66 years) diagnosed with pancreas cancer between 2005 and 2015 in the linked Surveillance, Epidemiology, and End Results-Medicare dat...
Of 32,783 patients, 18.7% were previously diagnosed with another cancer. The most common previous cancers included prostate (29.0%), breast (18.9%), or colorectal (9.7%) cancer. More than half of prev...
Given nearly equivalent survival compared to those without previous cancer, cancer survivors newly diagnosed with pancreas cancer should be considered for inclusion in pancreas cancer clinical trials....
We investigated sleep disturbances among cancer survivors compared to similarly aged women without cancer history....
We identified 2067 women with a history of cancer other than breast or non-melanoma skin cancer at enrollment in the Sister Study, a US-wide cohort of women with a family history of breast cancer. Can...
At enrollment, cancer survivors were on average 13.8 years (range=0, 62) from diagnosis. After adjustment for age at enrollment and depression, diabetes, hypertension, and menopausal status prior to t...
Addressing sleep disturbances may improve well-being for cancer survivors....
To explore: 1) the unmet needs of breast cancer patients; 2) the sexual needs experienced by breast cancer survivors; 3) the experiences of cancer patients at the time of relapse, including the biopsy...
Interpretative phenomenological qualitative research by conducting direct in-depth interviews with participants who met the inclusion criteria. Sample analyzed were breast cancer survivors who had exp...
Themes identified for breast cancer patients with unmet needs were i) overcoming health problems in breast cancer survivors; ii) need to access the best health services; iii) women's unmet information...
Health-related problems of breast cancer survivors, such as fatigue and fear of cancer recurrence, can lead them to have trouble with social relationships, question their spirituality, and struggle wi...
This research aims to systematically review a comprehensive sample of websites (English-language) that provide information on nutrition after cancer treatment....
In consultation with cancer survivors and experts, we developed search strings for an internet search (incognito mode in Google Chrome) to be completed in six English-speaking countries (Ireland, the ...
Initially, 720 links were found, with 159 eligible for inclusion. Those eligible for review were charity/support/non-governmental organisation weblinks (49.1%) that originated in the United States (42...
Cancer survivors seeking nutrition information online may encounter difficulty locating advice, and where they do, it is unlikely to contain guidance on implementation into day-to-day life. This is co...
Breast cancer patients commonly present to their OBGYN during the process of diagnosis and treatment of breast cancer both for specific gynecologic needs and for primary care follow up. These patients...
Fear of cancer recurrence is common among survivors of adult-onset cancer and associated with increased distress, functional impairment, and health care utilization. However, little is known about the...
To characterize the prevalence of and risk factors for clinically significant fear of cancer recurrence in adult survivors of childhood cancer....
This cross-sectional investigation included participants recruited from the Childhood Cancer Survivor Study, a retrospective cohort study of long-term childhood cancer survivors treated at 31 institut...
Clinically significant fear of cancer recurrence was assessed via the Fear of Cancer Recurrence Inventory-Short Form. Poisson regression models estimated prevalence ratios (PRs) with 95% CIs adjusted ...
The final sample included 229 adult survivors of childhood cancer (115 female [50.2%]; mean [SD] age, 39.6 [9.9] years; mean [SD] time since diagnosis, 31.7 [8.4] years). Among survivors, 38 (16.6%; 9...
Decades following treatment, one-third of childhood cancer survivors in this study reported elevated fear their cancer will recur or a subsequent malignant neoplasm will develop. Findings suggest that...
Financial burden and distress are high in patients with thyroid cancer. However, little has been done to evaluate potential interventions to mitigate financial toxicity in survivors. This review will ...
Thyroid cancer incidence has nearly tripled in the past decades, and cost of treatment is predicted to rise more than other cancers over the next decade. With mean age of diagnosis at 51 years, most p...
Thyroid cancer survivors have high rates of financial toxicity, and there remains need for longitudinal studies to evaluate how financial burden may change during the treatment process while also asse...
Little is known about cancer survivors' needs in Alaska. To address this knowledge gap, the Alaska Cancer Partnership conducted a needs assessment survey; our objectives were to identify unmet needs o...
Cancer survivors were identified using data from the Alaska Cancer Registry. A random sample of 2,600 individuals was selected to receive the survey, which assessed unmet needs across the following do...
We received 335 survey responses, for a response of 13.7%. Only 29.9% of cancer survivors expressed that all their needs were met. The most highly ranked unmet needs were as follows: help to reduce st...
This assessment provided some of the first information regarding the needs of Alaska's cancer survivors. These results will be used by Alaska Cancer Partnership members across the state to inform heal...